开发了降低KRAS和SOS1的PROTACS降低KRAS和SOS1的开发
Gerhard Hamilton1, Marie-Therese Eggerstorfer1, Sandra Stickler1
1Institute of Pharmacology, Medical University of Vienna, Vienna, 1090, Austria.
Oncology research
|July 26, 2024
概括
新的蛋白质溶解向嵌合体 (PROTACs) 向了基尔斯顿大鼠肉瘤病毒-son of sevenless 1 (KRAS-SOS1) 轴,为增强癌症治疗提供了潜力. 这些PROTACs降解目标蛋白质,显示出超越当前KRAS G12C抑制剂的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- KRAS-SOS1轴对胰腺,结肠和肺癌的瘤生长至关重要.
- 克拉斯G12C抑制剂在治疗KRAS突变瘤的有效性和持续时间有限.
- 向蛋白质分解的仿真体 (PROTACs) 为癌症治疗提供了一种新的蛋白质降解方法.
研究的目的:
- 开发和评估针对KRAS-SOS1轴的PROTAC,以改善癌症治疗.
- 评估KRAS和SOS1导向的PROTACs的有效性和潜在限制.
主要方法:
- 通过将KRAS或SOS1定向抑制剂与VHL或CRBN配体结合,开发PROTACs.
- 在体外和体内对PROTAC活性和疗效的评估.
- 研究对PROTACs的耐药性机制,包括E3结合酶失活.
主要成果:
- 几种开发的PROTACs与其母抑制剂相比,在体外和体内表现出增强的活性.
- 对于一些PROTAC结构,正常组织中的潜在毒性仍然不清楚.
- 抵抗机制涉及CRBN或VHL E3结合酶组件的下调或失活.
结论:
- 针对KRAS和SOS1的PROTACs代表了增强抗瘤活性对抗KRAS驱动的癌症的有希望的策略.
- 需要进一步的研究来解决PROTAC的毒性,并克服临床应用的耐药性机制.
- 这些高度活跃的PROTACs的临床转化面临着需要进一步研究的挑战.
关键词:
头脑黄金是什么意思基尔斯大鼠肉瘤病毒 (KRAS) 病毒针对蛋白质分解的仿真体 (PROTACs)没有七个孩子的儿子1 (SOS1)·希佩尔-林道夫 (Hippel-Lindau) 是一个著名的作家.更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.7K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
相关概念视频
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K